Additional Information

Description

Hydromorphone 40 mg/20 mL is a potent opioid analgesic formulated for parenteral administration. It is indicated for the management of severe pain that is unresponsive to alternative treatment options. Hydromorphone functions by binding to mu-opioid receptors in the central nervous system, altering the perception of and emotional response to pain.

This formulation is supplied in a 20 mL vial, with a concentration of 40 mg per 20 mL (2 mg/mL). It is typically administered intravenously, intramuscularly, or subcutaneously by a trained healthcare professional, allowing for precise dosing and rapid therapeutic effects. The controlled delivery of hydromorphone ensures effective pain relief.

As a Schedule II controlled substance, hydromorphone has a high potential for abuse, dependence, and addiction. Adverse effects commonly associated with its use include nausea, vomiting, constipation, dizziness, and respiratory depression, which necessitates close monitoring during administration.